Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?

Sepsis is the most common cause of admission to intensive care units worldwide. Sepsis patients frequently suffer from sepsis-associated encephalopathy (SAE) reflecting acute brain dysfunction. SAE may result in increased mortality, extended length of hospital stay, and long-term cognitive dysfuncti...

Full description

Saved in:
Bibliographic Details
Published in:Critical care (London, England) England), 2023-05, Vol.27 (1), p.214-214, Article 214
Main Authors: Bircak-Kuchtova, Barbora, Chung, Ha-Yeun, Wickel, Jonathan, Ehler, Johannes, Geis, Christian
Format: Article
Language:English
Subjects:
Alzheimer's disease
Biomarker
Biomarkers
Brain dysfunction
Care and treatment
Caregivers
Cognitive ability
Complications and side effects
Consciousness
Critical care
Cytoplasmic filaments
Delirium
Encephalopathy
Health aspects
Hospital patients
Intensive care
Medical prognosis
Memory
Mental disorders
Mortality
Neurofilament light chain
Patients
Prevention
Protein expression
Review
Risk factors
Sepsis
Trauma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c564t-66b2aef09891b291d015b813fa2c5adb70b7390b5cc731cb0c1bce45c4942c193
cites cdi_FETCH-LOGICAL-c564t-66b2aef09891b291d015b813fa2c5adb70b7390b5cc731cb0c1bce45c4942c193
container_end_page 214
container_issue 1
container_start_page 214
container_title Critical care (London, England)
container_volume 27
creator Bircak-Kuchtova, Barbora
Chung, Ha-Yeun
Wickel, Jonathan
Ehler, Johannes
Geis, Christian
description Sepsis is the most common cause of admission to intensive care units worldwide. Sepsis patients frequently suffer from sepsis-associated encephalopathy (SAE) reflecting acute brain dysfunction. SAE may result in increased mortality, extended length of hospital stay, and long-term cognitive dysfunction. The diagnosis of SAE is based on clinical assessments, but a valid biomarker to identify and confirm SAE and to assess SAE severity is missing. Several blood-based biomarkers indicating neuronal injury have been evaluated in sepsis and their potential role as early diagnosis and prognostic markers has been studied. Among those, the neuroaxonal injury marker neurofilament light chain (NfL) was identified to potentially serve as a prognostic biomarker for SAE and to predict long-term cognitive impairment. In this review, we summarize the current knowledge of biomarkers, especially NfL, in SAE and discuss a possible future clinical application considering existing limitations.
doi_str_mv 10.1186/s13054-023-04497-4
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_00ed3cd33a524f9b96434688519c47b7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A751369792</galeid><doaj_id>oai_doaj_org_article_00ed3cd33a524f9b96434688519c47b7</doaj_id><sourcerecordid>A751369792</sourcerecordid><originalsourceid>FETCH-LOGICAL-c564t-66b2aef09891b291d015b813fa2c5adb70b7390b5cc731cb0c1bce45c4942c193</originalsourceid><addsrcrecordid>eNptUstu1DAUjRCIloEfYIEssWGT4ndiNtWo4lGpgg1I7CzHuZl4cOJge6jK1-PplMIg5IVf55yrc--pqucEnxHSyteJMCx4jSmrMeeqqfmD6pRwKWuJ1deH5cwkr1vBxEn1JKUtxqRpJXtcnbCGCoUVOa1-foRdDIPzZoI5I-82Y0Z2NG5OKAdkUoKUUIIluVSXW7DOZOgRzBaW0fiwmDzevEHrCOgaUJhRHgHlaOy3wr82sUfWu9lZ45GbFg_7Mia7MJ8_rR4Nxid4drevqi_v3n6--FBffXp_ebG-qq2QPNdSdtTAgFWrSEcV6TERXUvYYKgVpu8a3DVM4U5Y2zBiO2xJZ4ELyxWnlii2qi4Pun0wW71EN5l4o4Nx-vYhxI02MTvrQWMMPbM9Y0ZQPqhOSc64bFtBlOVNqbOqzg9ay66boLfFTDT-SPT4Z3aj3oQfmpQp4TKPovDqTiGG7ztIWU8uWfDezBB2SdOWEln8NG2BvvwHug27OJde7VENwYxR8Qe1McWBm4ew7_5eVK8bUUqqRtGCOvsPqqweJmfDDCUCcEygB4KNIaUIw71JgvU-fvoQP12M6dv4aV5IL_5uzz3ld97YL9Jr1fQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2827103325</pqid></control><display><type>article</type><title>Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Bircak-Kuchtova, Barbora ; Chung, Ha-Yeun ; Wickel, Jonathan ; Ehler, Johannes ; Geis, Christian</creator><creatorcontrib>Bircak-Kuchtova, Barbora ; Chung, Ha-Yeun ; Wickel, Jonathan ; Ehler, Johannes ; Geis, Christian</creatorcontrib><description>Sepsis is the most common cause of admission to intensive care units worldwide. Sepsis patients frequently suffer from sepsis-associated encephalopathy (SAE) reflecting acute brain dysfunction. SAE may result in increased mortality, extended length of hospital stay, and long-term cognitive dysfunction. The diagnosis of SAE is based on clinical assessments, but a valid biomarker to identify and confirm SAE and to assess SAE severity is missing. Several blood-based biomarkers indicating neuronal injury have been evaluated in sepsis and their potential role as early diagnosis and prognostic markers has been studied. Among those, the neuroaxonal injury marker neurofilament light chain (NfL) was identified to potentially serve as a prognostic biomarker for SAE and to predict long-term cognitive impairment. In this review, we summarize the current knowledge of biomarkers, especially NfL, in SAE and discuss a possible future clinical application considering existing limitations.</description><identifier>ISSN: 1364-8535</identifier><identifier>EISSN: 1466-609X</identifier><identifier>EISSN: 1364-8535</identifier><identifier>EISSN: 1366-609X</identifier><identifier>DOI: 10.1186/s13054-023-04497-4</identifier><identifier>PMID: 37259091</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Alzheimer's disease ; Biomarker ; Biomarkers ; Brain dysfunction ; Care and treatment ; Caregivers ; Cognitive ability ; Complications and side effects ; Consciousness ; Critical care ; Cytoplasmic filaments ; Delirium ; Encephalopathy ; Health aspects ; Hospital patients ; Intensive care ; Medical prognosis ; Memory ; Mental disorders ; Mortality ; Neurofilament light chain ; Patients ; Prevention ; Protein expression ; Review ; Risk factors ; Sepsis ; Trauma</subject><ispartof>Critical care (London, England), 2023-05, Vol.27 (1), p.214-214, Article 214</ispartof><rights>2023. The Author(s).</rights><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c564t-66b2aef09891b291d015b813fa2c5adb70b7390b5cc731cb0c1bce45c4942c193</citedby><cites>FETCH-LOGICAL-c564t-66b2aef09891b291d015b813fa2c5adb70b7390b5cc731cb0c1bce45c4942c193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230136/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2827103325?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,38516,43895,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37259091$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bircak-Kuchtova, Barbora</creatorcontrib><creatorcontrib>Chung, Ha-Yeun</creatorcontrib><creatorcontrib>Wickel, Jonathan</creatorcontrib><creatorcontrib>Ehler, Johannes</creatorcontrib><creatorcontrib>Geis, Christian</creatorcontrib><title>Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?</title><title>Critical care (London, England)</title><addtitle>Crit Care</addtitle><description>Sepsis is the most common cause of admission to intensive care units worldwide. Sepsis patients frequently suffer from sepsis-associated encephalopathy (SAE) reflecting acute brain dysfunction. SAE may result in increased mortality, extended length of hospital stay, and long-term cognitive dysfunction. The diagnosis of SAE is based on clinical assessments, but a valid biomarker to identify and confirm SAE and to assess SAE severity is missing. Several blood-based biomarkers indicating neuronal injury have been evaluated in sepsis and their potential role as early diagnosis and prognostic markers has been studied. Among those, the neuroaxonal injury marker neurofilament light chain (NfL) was identified to potentially serve as a prognostic biomarker for SAE and to predict long-term cognitive impairment. In this review, we summarize the current knowledge of biomarkers, especially NfL, in SAE and discuss a possible future clinical application considering existing limitations.</description><subject>Alzheimer's disease</subject><subject>Biomarker</subject><subject>Biomarkers</subject><subject>Brain dysfunction</subject><subject>Care and treatment</subject><subject>Caregivers</subject><subject>Cognitive ability</subject><subject>Complications and side effects</subject><subject>Consciousness</subject><subject>Critical care</subject><subject>Cytoplasmic filaments</subject><subject>Delirium</subject><subject>Encephalopathy</subject><subject>Health aspects</subject><subject>Hospital patients</subject><subject>Intensive care</subject><subject>Medical prognosis</subject><subject>Memory</subject><subject>Mental disorders</subject><subject>Mortality</subject><subject>Neurofilament light chain</subject><subject>Patients</subject><subject>Prevention</subject><subject>Protein expression</subject><subject>Review</subject><subject>Risk factors</subject><subject>Sepsis</subject><subject>Trauma</subject><issn>1364-8535</issn><issn>1466-609X</issn><issn>1364-8535</issn><issn>1366-609X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUstu1DAUjRCIloEfYIEssWGT4ndiNtWo4lGpgg1I7CzHuZl4cOJge6jK1-PplMIg5IVf55yrc--pqucEnxHSyteJMCx4jSmrMeeqqfmD6pRwKWuJ1deH5cwkr1vBxEn1JKUtxqRpJXtcnbCGCoUVOa1-foRdDIPzZoI5I-82Y0Z2NG5OKAdkUoKUUIIluVSXW7DOZOgRzBaW0fiwmDzevEHrCOgaUJhRHgHlaOy3wr82sUfWu9lZ45GbFg_7Mia7MJ8_rR4Nxid4drevqi_v3n6--FBffXp_ebG-qq2QPNdSdtTAgFWrSEcV6TERXUvYYKgVpu8a3DVM4U5Y2zBiO2xJZ4ELyxWnlii2qi4Pun0wW71EN5l4o4Nx-vYhxI02MTvrQWMMPbM9Y0ZQPqhOSc64bFtBlOVNqbOqzg9ay66boLfFTDT-SPT4Z3aj3oQfmpQp4TKPovDqTiGG7ztIWU8uWfDezBB2SdOWEln8NG2BvvwHug27OJde7VENwYxR8Qe1McWBm4ew7_5eVK8bUUqqRtGCOvsPqqweJmfDDCUCcEygB4KNIaUIw71JgvU-fvoQP12M6dv4aV5IL_5uzz3ld97YL9Jr1fQ</recordid><startdate>20230531</startdate><enddate>20230531</enddate><creator>Bircak-Kuchtova, Barbora</creator><creator>Chung, Ha-Yeun</creator><creator>Wickel, Jonathan</creator><creator>Ehler, Johannes</creator><creator>Geis, Christian</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20230531</creationdate><title>Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?</title><author>Bircak-Kuchtova, Barbora ; Chung, Ha-Yeun ; Wickel, Jonathan ; Ehler, Johannes ; Geis, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c564t-66b2aef09891b291d015b813fa2c5adb70b7390b5cc731cb0c1bce45c4942c193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Alzheimer's disease</topic><topic>Biomarker</topic><topic>Biomarkers</topic><topic>Brain dysfunction</topic><topic>Care and treatment</topic><topic>Caregivers</topic><topic>Cognitive ability</topic><topic>Complications and side effects</topic><topic>Consciousness</topic><topic>Critical care</topic><topic>Cytoplasmic filaments</topic><topic>Delirium</topic><topic>Encephalopathy</topic><topic>Health aspects</topic><topic>Hospital patients</topic><topic>Intensive care</topic><topic>Medical prognosis</topic><topic>Memory</topic><topic>Mental disorders</topic><topic>Mortality</topic><topic>Neurofilament light chain</topic><topic>Patients</topic><topic>Prevention</topic><topic>Protein expression</topic><topic>Review</topic><topic>Risk factors</topic><topic>Sepsis</topic><topic>Trauma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bircak-Kuchtova, Barbora</creatorcontrib><creatorcontrib>Chung, Ha-Yeun</creatorcontrib><creatorcontrib>Wickel, Jonathan</creatorcontrib><creatorcontrib>Ehler, Johannes</creatorcontrib><creatorcontrib>Geis, Christian</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Critical care (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bircak-Kuchtova, Barbora</au><au>Chung, Ha-Yeun</au><au>Wickel, Jonathan</au><au>Ehler, Johannes</au><au>Geis, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?</atitle><jtitle>Critical care (London, England)</jtitle><addtitle>Crit Care</addtitle><date>2023-05-31</date><risdate>2023</risdate><volume>27</volume><issue>1</issue><spage>214</spage><epage>214</epage><pages>214-214</pages><artnum>214</artnum><issn>1364-8535</issn><eissn>1466-609X</eissn><eissn>1364-8535</eissn><eissn>1366-609X</eissn><abstract>Sepsis is the most common cause of admission to intensive care units worldwide. Sepsis patients frequently suffer from sepsis-associated encephalopathy (SAE) reflecting acute brain dysfunction. SAE may result in increased mortality, extended length of hospital stay, and long-term cognitive dysfunction. The diagnosis of SAE is based on clinical assessments, but a valid biomarker to identify and confirm SAE and to assess SAE severity is missing. Several blood-based biomarkers indicating neuronal injury have been evaluated in sepsis and their potential role as early diagnosis and prognostic markers has been studied. Among those, the neuroaxonal injury marker neurofilament light chain (NfL) was identified to potentially serve as a prognostic biomarker for SAE and to predict long-term cognitive impairment. In this review, we summarize the current knowledge of biomarkers, especially NfL, in SAE and discuss a possible future clinical application considering existing limitations.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>37259091</pmid><doi>10.1186/s13054-023-04497-4</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1364-8535
ispartof Critical care (London, England), 2023-05, Vol.27 (1), p.214-214, Article 214
issn 1364-8535
1466-609X
1364-8535
1366-609X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_00ed3cd33a524f9b96434688519c47b7
source ProQuest - Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Alzheimer's disease
Biomarker
Biomarkers
Brain dysfunction
Care and treatment
Caregivers
Cognitive ability
Complications and side effects
Consciousness
Critical care
Cytoplasmic filaments
Delirium
Encephalopathy
Health aspects
Hospital patients
Intensive care
Medical prognosis
Memory
Mental disorders
Mortality
Neurofilament light chain
Patients
Prevention
Protein expression
Review
Risk factors
Sepsis
Trauma
title Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A26%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurofilament%20light%20chains%20to%20assess%20sepsis-associated%20encephalopathy:%20Are%20we%20on%20the%20track%20toward%20clinical%20implementation?&rft.jtitle=Critical%20care%20(London,%20England)&rft.au=Bircak-Kuchtova,%20Barbora&rft.date=2023-05-31&rft.volume=27&rft.issue=1&rft.spage=214&rft.epage=214&rft.pages=214-214&rft.artnum=214&rft.issn=1364-8535&rft.eissn=1466-609X&rft_id=info:doi/10.1186/s13054-023-04497-4&rft_dat=%3Cgale_doaj_%3EA751369792%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c564t-66b2aef09891b291d015b813fa2c5adb70b7390b5cc731cb0c1bce45c4942c193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2827103325&rft_id=info:pmid/37259091&rft_galeid=A751369792&rfr_iscdi=true